An Overview of Randomised Studies Comparing 5-HT 3 Receptor Antagonists to Conventional Anti-emetics in the Prophylaxis of Acute Chemotherapy-induced Vomiting

By Jantunen I.T.   Kataja V.V.   Muhonen T.T.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 67-74

Elsevier

Access to resources Recommend Favorite

Efficacy of 5-HT 3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review

By Tramer M.R.   Reynolds D.J.M.   Stoner N.S.   Moore R.A.   McQuay H.J.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1836-1844

Elsevier

Access to resources Recommend Favorite

5-HT 3 Receptor Antagonists: Differences and Similarities

By Roila F.   Ballatori E.   Tonato M.   Del Favero A.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1364-1370

Elsevier

Access to resources Recommend Favorite

Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT₃ receptor antagonists in cancer patients

By Yamada Yasuhiko   Sugiura Munetoshi   Higo Kozue   Ozeki Takeshi   Takayanagi Risa   Okuyama Kiyoshi   Yamamoto Koujirou   Satoh Hitoshi   Sawada Yasufumi   Iga Tatsuji  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite